Winthrop Partners - WNY’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$333K Sell
4,530
-100
-2% -$7.25K 0.23% 83
2019
Q2
$332K Sell
4,630
-600
-11% -$42.6K 0.25% 81
2019
Q1
$357K Sell
5,230
-1,270
-20% -$82K 0.28% 78
2018
Q4
$387K Sell
6,500
-650
-9% -$40.7K 0.36% 69
2018
Q3
$479K Sell
7,150
-1,450
-17% -$96.6K 0.39% 70
2018
Q2
$557K Sell
8,600
-1,200
-12% -$78.5K 0.46% 64
2018
Q1
$700K Hold
9,800
0.54% 55
2017
Q4
$698K Buy
+9,800
New +$716K 0.57% 57

Other funds holding CL

Winthrop Partners - WNY's CL Position: Q3 2019 in Review

Winthrop Partners - WNY reduced its Colgate-Palmolive (CL) stake by 2.2% in Q3 2019, selling an estimated $7.25K and leaving 4,530 shares worth $333K. The position accounts for 0.23% of the portfolio, ranked #83.

Winthrop Partners - WNY first reported a position in CL in Q4 2017 and has held it in 8 quarters since. The position peaked at $700K in Q1 2018. 1,446 funds tracked by Wall St. Rank hold CL as of Q3 2019.

  • Winthrop Partners - WNY held 4,530 shares of Colgate-Palmolive worth $333K as of Q3 2019.
  • Winthrop Partners - WNY sold 100 Colgate-Palmolive shares in Q3 2019, an estimated $7.25K.
  • Colgate-Palmolive made up 0.23% of Winthrop Partners - WNY's portfolio in Q3 2019, its #83 holding.
  • Winthrop Partners - WNY first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 8 quarters since.
  • Winthrop Partners - WNY's Colgate-Palmolive position peaked at $700K in Q1 2018.
  • 1,446 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.